Jessica Queller does interview with NPR.ORG
BRCA NEWSWORTHY
If you would like to hear Jessica Queller’s interview go here:
Olaparib a new drug for genetic breast cancer article from The Times Online 6/1/09
BRCA NEWSWORTHY
New drug olaparib offers hope to women with genetic breast cancer by David Rose
Follow this link: http://www.timesonline.co.uk/tol/life_and_style/health/article6400852.ece
Olaparib is made by AstraZeneca & is being used in clinical trials to treat & or prevent cancer in high risk or BRCA families. They feel this drug is very promising in blocking the protein that makes cancer cells –causing only the cancer cell to either die or shrink. (BRCA patients have the mutated gene that is supposed to repair or fix damaged DNA—therefore when the repair doesn’t work properly mistakes in the DNA accumulate, do not repair & cancer develops.)
Tamoxifen & antidepressant article from Bloomberg.com 5/30/09
BRCA NEWSWORTHY
Antidepressants cut effectiveness of Tamoxifen in Breast Cancer by Lisa Rapaport
Please follow this link for the entire article: http://www.bloomberg.com/apps/news?pid=20601103&sid=acVRDiRcYWzQ&refer=news
I found this article worthy of passing on to you readers…ALWAYS DISCUSS ANY OF THESE THINGS WITH YOUR PHYSICIAN!
A study says…Prozac, Zoloft, Paxil when taken with Tamoxifen was more likely to inhibit the effectiveness of taking Tamoxifin therefore…increases the risk of your tumor returning when compared to women who didn’t take the above mentioned antidepressants. These antidepressants are known as SSRI’s (selective serotonin reuptake inhibitors) & they use the same supply of enzymes (found in our liver) to make them effective that Tamoxifin uses—therefore they have to share the supply of enzymes making Tamoxifin weaker. SSRI’s also include the medications Celexa & Lexipro- but Paxil was found in the study to be the strongest in blocking the enzyme.
Effexor was mentioned as not interfering with the effects of Tamoxifen.
Experimental Cancer Drug article from USA Today 5/27/09
BRCA NEWSWORTHY
Experimental cancer drugs cut tumors off from repair tools by Liz Szabo
Follow this link: http://www.usatoday.com/news/health/2009-05-27-asco-cancer-drugs_N.htm
These new experimental cancer drugs are called PARP inhibitors & they are being used in women whose tumors don’t respond well to hormones or Herceptin. These drugs are being studied in BRCA positive patients as well as cancer patients. BRCA patients have the mutated gene that is supposed to repair or fix damaged DNA—therefore when the repair doesn’t work properly mistakes in the DNA accumulate, do not repair & cancer develops. Apparently these PARP inhibitors are a repair enzyme that clean up & repair these damaged cells.
ARMYOFWOMEN.ORG
BRCA NEWSWORTHY
6/5/09
Susan Love, MD. (breast cancer surgeon/activist) is determined to recruit women of all backgrounds & ages & help researchers move forward with finding a cure. All you have to do is go to this website: http://www.armyofwomen.org/ register & wait to be emailed! Then choose any study that you would like to participate in-or just read & follow along!
Here is their invite a friend letter from their website http://www.armyofwomen.org/.
The Love/Avon Army of Women offers women the opportunity to partner with the scientists who are conducting research that will end this disease–once and for all.
Breast cancer has been around for decades, but it does not have to be our future. We can be the generation that stops breast cancer once and for all by figuring out what causes this disease and how to prevent it!
Sign up for your sister, mother, daughter, granddaughter, best friend, and the woman you met last week. This is YOUR chance to be part of the research that will end breast cancer.
It takes a just a minute to join. But the impact we will have will last a lifetime.
Please Join Me in Being One in a Million! (from: armyofwomen.org)